Gossamer Bio, Inc.
Gossamer Bio, Inc.（GOSS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
goss · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$1.00
Consensus
$0.77
+338.1% upside
Low
$0.30
Median: $1 · Last Close: $0.17
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$0.77
338.1% upside
High Target
$1
471.4%
Low Target
$0.3
71.4%
Current Price
$0.17
as of today
Based on analyst price targets, the GOSS stock price prediction for the next 12 months ranges from $0.3 to $1. The consensus GOSS price forecast of $0.77 implies 338.1% upside from the current price of $0.17.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.17 | ↓ 5.00% |
1-day model range: $0.16–$0.17. Peak: $0.17 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · GOSS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-19 | Barclays | Maintains | Underweight→Underweight |
| 2026-03-23 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2026-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-05 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-24 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-02-24 | Barclays | Downgrade ↓ | Overweight→Underweight |
| 2026-02-24 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-01-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-11 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Gossamer Bio, Inc. (GOSS) stock. Of the recent 79 rating actions, 1 were upgrades and 8 were downgrades. 17 analysts currently cover GOSS.
分析师推荐趋势
GOSS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$36M
↓ 72.5% YoY
Revenue Next Year
$53M
↑ 45.7% YoY
EPS This Year
$-0.44
EPS Next Year
$-0.11
↓ 75.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast GOSS EPS of $-0.44 for the current fiscal year, based on estimates from 5 analysts. The GOSS revenue forecast is $36M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
GOSS 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。GOSS 的共识目标价为 $0.77（+338.1% 上行空间），分析师共识为 Buy。
GOSS 的短期预测（明日）为 $0.17（-5.00%）。
Gossamer Bio, Inc. 在 NASDAQ 上市，代码 GOSS。GOSS 在 2027 年的整体展望偏积极，在覆盖分析师中约 53% 对应 Buy 共识。
常见问题
GOSS 预测 · 8 个问题根据 17 位华尔街分析师，GOSS 的 12 个月平均目标价为 $0.77，最高 $1.00、最低 $0.30。若有图表，中位目标价可在上方查看。相对当前价 $0.17，隐含约 +338.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.